Status:
COMPLETED
AdheRence to Inhaled Corticosteroids in Asthma
Lead Sponsor:
Duke University
Conditions:
Medication Adherence
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goa...
Detailed Description
The investigators will evaluate ARICA in Duke primary care clinics to study its feasibility and acceptability using a quasi-experimental pre-post study design. The study will enroll between 32 and 48 ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- At least 18 years of age
- Self-identifying African American
- Self-reported current asthma
- Prescribed an inhaled corticosteroid (alone or combination) for ≥ 1 month
- Presented at a Duke Primary Care clinic visit within the past 3 years or is establishing care at Duke Primary Care
- Follow up Duke Primary Care visit within the next 6 months
- Exclusion Criteria:
- Unable or unwilling to provide informed consent
Exclusion
Key Trial Info
Start Date :
February 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2020
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03769519
Start Date
February 27 2020
End Date
August 19 2020
Last Update
December 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Un.
Durham, North Carolina, United States, 27701